Bavarian Nordic
Tracked across 5 events · 48 articles · First seen Apr 07, 2026 · Last active Sep 04, 2026
Live sentiment trends, attention charts, and prominence tracking available on the
Ergen Dashboard
Business
Impact: Bavarian Nordic is repurchasing its own shares to adjust its capital structure, which is generally seen as a positive signal to the market.
Jun 02, 2026 · 22 articles
Regulatory
Impact: Bavarian Nordic is the vaccine developer and manufacturer; the submission in Brazil expands its market reach beyond travel vaccines into endemic regions, potentially boosting sales.
Jul 13, 2026 · 6 articles
Regulatory
Impact: Bavarian Nordic is the vaccine developer and manufacturer; the EU approval for children expands its market and strengthens its position in mpox/smallpox preparedness, likely boosting revenue prospects.
Aug 07, 2026 · 6 articles
Business
Bavarian Nordic A/S announced on August 21, 2026, a new share buy-back program of up to DKK 750 million, and on September 1, 2026, launched the first tranche of up to DKK 250 million. The…
Impact: Bavarian Nordic is the central entity, initiating a DKK 750 million buy-back program and terminating its revolving credit facility. This reflects strong cash generation and a commitment to shareholder returns, likely positively impacting its stock.
Aug 21, 2026 · 8 articles
Business
Impact: Bavarian Nordic is the issuer whose shares were traded by insiders. The sales may slightly dampen investor sentiment, but the company's fundamentals remain unchanged.
Aug 25, 2026 · 6 articles
70
Bavarian Nordic launched share buy-backBavarian Nordic launches...
50
Bavarian Nordic terminated revolving credit facilityBavarian Nordic launches...
40
Bavarian Nordic appointed lead manager NordeaBavarian Nordic launches...
ERGEN INTELLIGENCE
Track Bavarian Nordic live
Set up alerts, explore relationships, view sentiment trends, and monitor how events impact this entity in real time.
Open Dashboard